BRIEF-Gansu Longshenrongfa Pharmaceutical Industry sees 2016 9-mth net pro… – Reuters

Oct 17 Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd :

* Sees net profit for 2016 Q1-Q3 to decrease by 10 percent to 18 percent, or to be 35.6 million yuan to 39.1 million yuan

* Says the net profit of 2015 Q1-Q3 was 43.4 million yuan

Source text in Chinese:goo.gl/DoRvY0

Further company coverage: (Beijing Headline News)

Next In Healthcare

BRIEF-Teleflex receives FDA clearance for Arrow Midline with Chlorag+ard Technology

* Has received FDA 510(k) clearance to market its Arrow Midline with Chlorag(+)Ard Technology. Source text for Eikon: Further company coverage:

BRIEF-Shanghai Fudan-Zhangjiang Bio-pharma unit obtained drug approval

Oct 17 Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd :

BRIEF-Ra Pharmaceuticals sees IPO of 5.8 million shares of its common stock

* Ra Pharmaceuticals Inc sees IPO of 5.8 million shares of its common stock priced between $ 12.00 and $ 14.00 per share Source text – http://bit.ly/2dm5rE2

From Around the Web Promoted by Taboola

Editor’s Pick

BRIEF-Gansu Longshenrongfa Pharmaceutical Industry sees 2016 9-mth net pro… – Reuters

BRIEF-Gansu Longshenrongfa Pharmaceutical Industry sees 2016 9-mth net pro… – Reuters

Next In Healthcare

BRIEF-Teleflex receives FDA clearance for Arrow Midline with Chlorag+ard Technology

BRIEF-Shanghai Fudan-Zhangjiang Bio-pharma unit obtained drug approval

BRIEF-Ra Pharmaceuticals sees IPO of 5.8 million shares of its common stock

From Around the Web Promoted by Taboola

Editor’s Pick

Leave a Reply

Recently Commented

Archives by Tag

Recent Entries

Photo Gallery